RELAPSE
Clinical trials for RELAPSE explained in plain language.
Never miss a new study
Get alerted when new RELAPSE trials appear
Sign up with your email to follow new studies for RELAPSE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough anemia: daratumumab trial launches
Disease control Not yet recruitingThis study tests daratumumab, a drug that targets certain immune cells, in 37 people with aplastic anemia that hasn't improved with standard treatments. The first part checks safety and the right dose, and the second part looks at whether it can improve blood cell counts. The goa…
Matched conditions: RELAPSE
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Simple blood test could predict transplant complications
Knowledge-focused Not yet recruitingThis study looks at a new method to measure special immune cells called iNKT cells in the blood of patients who have had a stem cell transplant. These cells may help predict serious complications like graft-versus-host disease (GvHD) and relapse. Researchers will test 75 adults w…
Matched conditions: RELAPSE
Sponsor: University Hospital Pilsen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
New blood test could predict pancreatic cancer return
Knowledge-focused Not yet recruitingThis study looks at a new way to detect cancer cells in the portal vein blood of people with pancreatic cancer. The goal is to see if these cells can warn early if the cancer comes back or spreads. The study will involve 20 participants and uses a special ultrasound-guided proced…
Matched conditions: RELAPSE
Sponsor: Huazhong University of Science and Technology • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC